Peptidyl arginine deiminase inhibitor effect on hepatic fibrogenesis in a CCl4 pre-clinical model of liver fibrosis

American Journal of Translational Research

Volumn 5, Issue 4, 2013, Pages 465-469

  Vassiliadis, Efstathios ^a,b   Veidal, Sanne Skovgaard ^a,b   Kristiansen, Maria Nicoline Baandrup ^a   Hansen, Christina ^a   Jorgensen, Mia ^a   Leeming, Diana J ^a   Karsdal, Morten ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biomarker; Citrulline; Liver fibrosis; PAD inhibitor; VICM; Vimentin

Indexed keywords

CARBON TETRACHLORIDE; N A BENZOYL N5 (2 CHLORO 1 IMINOETHYL) L ORNITHINE AMIDE; PROTEIN ARGININE DEIMINASE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; HISTOLOGY; LIVER FIBROSIS; MALE; NONHUMAN; RAT;

ANIMALIA; RATTUS;

EID: 84878319474     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gyorgy B, Toth E, Tarcsa E, Falus A and Buzas EI. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006; 38: 1662-1677.
2. Shoulders MD and Raines RT. Collagen structure and stability. Annu Rev Biochem 2009; 78: 929-958.
3. Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M and Sato M. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc Natl Acad Sci U S A 2006; 103: 5291-5296.
4. György B, Tóth E, Tarcsa E, Falus A, Buzás EI. Citrullination: A posttranslational modification in health and disease. Int J Biochem Cell Biol 2006; 38: 1662-77.
5. Vossenaar ER, Zendman AJ, van Venrooij WJ and Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25: 1106-1118.
6. Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS and Fares C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron 2004; 35: 503-542.
7. Vossenaar ER, Zendman AJ, van Venrooij WJ and Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25: 1106-1118.
8. Vassiliadis E, Oliveira CP, vares-da-Silva MR, Zhang C, Carrilho FJ, Stefano JT, Rabelo F, Pereira L, Kappel CR, Henriksen K, Veidal SS, Vainer B, Duffin KL, Christiansen C, Leeming DJ and Karsdal M. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res 2012; 4: 403-414.
9. Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR and Holers VM. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 2011; 186: 4396-4404.
10. Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM and Karsdal MA. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem 2010; 43: 899-904.
11. Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR and Holers VM. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 2011; 186: 4396-4404.
12. Vassiliadis E, Oliveira CP, vares-da-Silva MR, Zhang C, Carrilho FJ, Stefano JT, Rabelo F, Pereira L, Kappel CR, Henriksen K, Veidal SS, Vainer B, Duffin KL, Christiansen C, Leeming DJ and Karsdal M. Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res 2012; 4: 403-414.